Listar por tema "systemic lupus erythematosus"
Mostrando ítems 1-5 de 5
-
Body mass index and fat influences the role of Bifidobacterium genus in lupus patients concerning fibrinogen levels
(Frontiers in Microbiology, 2024)Introduction: Metabolic disorders and autoimmune diseases elicit distinct yet interconnected manifestations of inflammation, which may be boosted by an excess of body adiposity. The purpose of this investigation was to ... -
Comment on: Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus
(Clinical and experimental rheumatology, 2025)[Resumen no disponible] -
Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on Bifidobacterium concerning liver status
(European Journal of Clinical Investigation, 2024)Background The relationship between systemic lupus erythematosus (SLE) and low-grade metabolic inflammation (MI) with the microbiota is crucial for understanding the pathogenesis of these diseases and developing effective ... -
Comparison of Metabolic Syndrome, Autoimmune and Viral Distinctive Inflammatory Related Conditions as Affected by Body Mass Index
(Journal of Clinical Medicine, 2024)Background: Metabolic inflammation (MI), long COVID (LC) and systemic lupus erythematosus (SLE) share some metabolic common manifestations and inflammatory pathophysiological similarities. Health-related quality of life ... -
Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
(Lupus Science & Medicine, 2025)Objective To assess the daily and weight-adjusted dosages of hydroxychloroquine (HCQ) and the effects on long-term remission in the Lupus-Cruces cohort. Methods Observational study of routine clinical care data. We ...
